In a regulatory filing, the company stated, “On November 21, 2025, the Board appointed Tony Isaac, President of the company and member of the Board, as the Acting Chief Executive Officer of the company and designated him as the company’s ‘principal executive officer.’ Mr. Isaac will also continue serving in his roles as President of the company and a member of the Board. The Acting CEO Appointment was made in connection with the departure of Mr. Hugh as Chief Financial Officer and Acting Chief Executive Officer of the company. The company did not enter into any consulting or employment agreement with Mr. Isaac in connection with the Acting CEO Appointment. There is no arrangement or understanding between Mr. Isaac and any other person pursuant to which Mr. Isaac was appointed as Acting Chief Executive Officer, and there is no family relationship between Mr. Isaac and any of the Company’s directors or other executive officers.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALTS:
- Trump partner ALT5 Sigma may violated SEC rules, Forbes reports
- ALT5 Sigma Delays Q3 2025 Financial Report Filing
- ALTS Upcoming Earnings Report: What to Expect?
- ALT5 Sigma Corporation Delays Quarterly Report Filing
- ALT5 Sigma Files Lawsuit Over Data Breach